| Sera Snow, RPH | |
|
518 Clay St, Arkadelphia, AR 71923-6024 | |
| (870) 246-5553 | |
| Not Available |
| Full Name | Sera Snow |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 518 Clay St, Arkadelphia, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407519093 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PD14588 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sera Snow, RPH Po Box 524, Arkadelphia, AR 71923-0524 Ph: (870) 246-5553 | Sera Snow, RPH 518 Clay St, Arkadelphia, AR 71923-6024 Ph: (870) 246-5553 |
News Archive
Octapharma, one of the largest human protein products manufacturers in the world, today announced that patients diagnosed with severe hemophilia A have started treatment with the first recombinant Factor VIII derived from a human cell line (Human-cl rhFVIII). Researchers are investigating pharmacokinetics, efficacy, safety and immunogenicity of Human-cl rhFVIII for previously treated patients with severe hemophilia A.
Lung Cancer Alliance (LCA) announced today a new internet link with a renown lung cancer research center at the 5th Affiliated Hospital of Sun Yat-Sen University, in Zhuhai, China.
Novavax, Inc. announced today positive results from the entire 1,000 subject Stage A of its two-stage pivotal study evaluating the safety and immunogenicity of Novavax's unadjuvanted 2009 A/H1N1 virus-like particle pandemic influenza vaccine.
The Associated Press reports that Ugandan President Yoweri Museveni has said that the anti-gay bill to be considered late next month or early March by the country's parliament "is too harsh and [he] has encouraged his ruling National Resistance Movement Party to overturn the death sentence provision. Several lawmakers have agreed and say they will push to remove the statute."
Eisai Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a five-day dosing regimen for Dacogen® (decitabine) for Injection to treat patients with myelodysplastic syndromes (MDS), a group of bone marrow diseases that alter the production of functional blood cells.
› Verified 3 days ago
Kimberly Payne, R.PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 518 Clay St, Arkadelphia, AR 71923 Phone: 870-246-5553 | |
Amy Babb, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2506 Wilshire Dr, Arkadelphia, AR 71923 Phone: 870-464-7559 | |
Dr. Edwin Dale Rutledge, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3002 Pine St, Arkadelphia, AR 71923 Phone: 870-246-3044 Fax: 870-245-1738 | |
Joseph Lance Williamson, DPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 624 Clay St, Arkadelphia, AR 71923 Phone: 888-212-6100 | |
Dr. Montana Mcadams Knight, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 131 N 26th St, Arkadelphia, AR 71923 Phone: 870-230-1809 | |
Gary Jack Newman, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2800 Pine St, Pine Plaza #5, Arkadelphia, AR 71923 Phone: 870-246-2015 Fax: 870-246-2915 | |
Dr. Catherine Plyler, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3050 Twin Rivers Dr, Arkadelphia, AR 71923 Phone: 870-245-1260 Fax: 870-245-1023 |